This agreement grants Menarini with immediate availability the exclusivity for the distribution - in 34 countries across
AFIAS-10 features an easy-to-use testing procedure directly from blood collection tubes with multi-testing performance that provides prompt results and allows the quick transmission of medical information. The all-in-one cartridge for the AFIAS platform is ready-to-use and contains all assay reagents. At present it is available for the measurement of over 50 parameters.
IGRA-TB is a cytokine release assay for quantitative determination of Interferon Gamma (IFN-) produced by human blood cells stimulated with Mycobacterium tuberculosis (MTB) antigens. In particular, the AFIAS IGRA-TB test is a simple, fast and cost-efficient fluorescent immuno-assay that can be used on the AFIAS-10 platform, an optimal latent tuberculosis testing solution for a large range of laboratories typology.
Tuberculosis is one of the leading causes of death globally1. According to WHO, an estimated 10.6 million people contracted tuberculosis worldwide and a total of 1.6 million people died from the disease in 20211. In
Fabio Piazzalunga, Global Head of A. Menarini Diagnostics S.r.l., stated: 'This agreement represents a great opportunity for our Company to contribute to the required efficiency of IVD services by bringing a highly innovative system for the immuno-assay single test market onto the EU market, being Afias-10 a perfect fit for decentralized use with cost effective positioning. The platform portfolio of assays includes tests with high medical value such as Latent Tuberculosis Testing. AFIAS-10 distribution will benefit from leveraging our strong sales and marketing forces deployed in the countries covered by the agreement'.
About
About A.
For more than 45 years, the company has been dedicated to helping healthcare professionals make safe and sustainable diagnoses, improving the quality of life of people all over the world.
A.
Contact:
Email: ufficiostampa@menarini.it
Tel: +39 055 56801
(C) 2023 Electronic News Publishing, source